Valley Cottage, New York, Dec. 13, 2017 -- Some of the key players in the global market for dry eye syndrome treatment include names such as Nicox, Candorvision, Novartis, Allergan Inc., Santen Pharmaceutical Co. Ltd., and Bridge Pharma Inc. among others. Among these companies, Santen, Novartis, and Allergen have made a dominant progress in the global market for dry eye syndrome treatment and are projected to continue their dominance over the course of the given forecast period of 2017 to 2027. In addition to this, the companies in the market are constantly striving to gain an upper hand over their rivals. As a result, they are engaging into strategic business activities such as partnerships, takeovers, and mergers to enhance their overall market presence.
According to the latest report by Future Market Insights, the global market for dry eye syndrome treatment is projected to be valued around US$3.56 Bn by the end of 2017. Furthermore, the market is projected to growth and is estimated to be valued at about US$6.61 Bn by the end of the given forecast period in 2027. The overall growth of the global dry eye syndrome treatment market is expected to be achieved with the help of a strong CAGR 6.4% over the course of the aforementioned forecast period of 2017 to 2027.
Get Research Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1215
From a geographical standpoint, the global market for dry eye syndrome treatment can be segmented into key regions such as North America, Latin America, Europe, Middle East and Africa, and Asia Pacific except Japan. Of these, the global market is expected to be dominated by North America. The overall valuation of the North America market for dry eye syndrome treatment is expected to reach more than US$2.5 Bn. This growth of the market is expected to be achieved with the help of an impressive CAGR of 6.7% during the given forecast period. The North America market is expected to offer a lucrative business opportunity of US$88.6 Mn in year 2018. Moreover, the market is estimated to create growing opportunities worth US$1.207 Bn from 2017 to 2027.
By the fall of 2027, the APEJ market for dry eye syndrome treatment is expected to reach a figure worth US$878.7 Mn. This growth of the APEJ market is expected to be achieved with the help of an impressive CAGR of 7.4% during the given forecast period. The APEJ market for dry eye syndrome treatment is projected to present an absolute business opportunity of around US$29.7 Mn in 2018 over 2017. The market is also expected to create an incremental business opportunities worth US$446.4 Mn during the period of 2017 to 2027.
Browse Report ToC: https://www.futuremarketinsights.com/reports/dry-eye-syndrome-treatment-market/toc
Product Innovations to Drive Growth of Market
More and more supplements producers are developing products specifically targeting at dry eye. One of the major reason for this is LASIK is becoming highly mainstream, and almost everyone who undergoes LASIK surgery will suffer from the dry eye syndrome within the first six months of their treatment. It is one of the chief driving factors for the growth of the global dry eye syndrome treatment market. Another important factor responsible for the growth of the global market is the launch of new product in the market. Recently, Candorvision introduced the CALMO eye spray which is the first eye spray free of preservatives in Canada. The leading players in the market are trying to create products that will take care of dry eye in different delivery channels so as to make sure better compliance of patients and utilization along with ample revenue generations.
No Price Regulations to Impede Market Growth
However, there are some factors that may impede the overall growth of the market in the coming years. One of the chief restraining factor for the growth of the global market is expected to be no control on the prices of the products. Without proper regulations on the prices, it might be difficult for the dry eye care products to reach masses.
Get Full Research Report: https://www.futuremarketinsights.com/checkout/1215
About Us
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Contact Us
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): +44(0)20-7692-8790
Sales: [email protected]
Website: http://www.futuremarketinsights.com


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



